Literature DB >> 16967311

Bifidobacterial diversity determined by culturing and by 16S rDNA sequence analysis in feces and mucosa from ten healthy Spanish adults.

Susana Delgado1, Adolfo Suárez, Baltasar Mayo.   

Abstract

This study aimed to identify the numerically predominant bifidobacterial species in feces and mucosa of healthy Spanish people and to determine their phenotypic and genetic diversity. To this end, both traditional culturing and molecular methods were used. A set of 196 bifidobacterial colonies was identified from the counting plates by sequencing of a stretch of their 16S rRNA gene. Representative isolates were phenotypically characterized by their carbohydrate fermentation profile and genotypically typed by RAPD-PCR. Four 16S rDNA libraries composed of 113 clones from two fecal and two mucosal samples were independently analyzed. Seven bifidobacterial species were identified by culturing, and six by 16S rDNA analysis. Both methodologies showed Bifidobacterium longum and B. pseudocatenulatum to predominate in feces and mucosa, although high interindividual variability was noted. High phenotypic variation was observed in the fermentation profile of different isolates from the same species. RAPD analysis showed that two to five strains made up the subjects' personal bifidobacterial communities. The identification of the dominant bifidobacterial species could be useful for the rational design, use, and evaluation of probiotics in our community.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16967311     DOI: 10.1007/s10620-006-9293-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  35 in total

Review 1.  The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota.

Authors:  V J McCracken; R G Lorenz
Journal:  Cell Microbiol       Date:  2001-01       Impact factor: 3.715

Review 2.  The intestinal LABs.

Authors:  Elaine E Vaughan; Maaike C de Vries; Erwin G Zoetendal; Kaouther Ben-Amor; Antoon D L Akkermans; Willem M de Vos
Journal:  Antonie Van Leeuwenhoek       Date:  2002-08       Impact factor: 2.271

3.  Phylogeny of the phototrophic rhizobium strain BTAi1 by polymerase chain reaction-based sequencing of a 16S rRNA gene segment.

Authors:  J P Young; H L Downer; B D Eardly
Journal:  J Bacteriol       Date:  1991-04       Impact factor: 3.490

4.  Analysis of fecal populations of bifidobacteria and lactobacilli and investigation of the immunological responses of their human hosts to the predominant strains.

Authors:  K Kimura; A L McCartney; M A McConnell; G W Tannock
Journal:  Appl Environ Microbiol       Date:  1997-09       Impact factor: 4.792

5.  Bifidobacterial diversity in human feces detected by genus-specific PCR and denaturing gradient gel electrophoresis.

Authors:  R M Satokari; E E Vaughan; A D Akkermans; M Saarela; W M de Vos
Journal:  Appl Environ Microbiol       Date:  2001-02       Impact factor: 4.792

6.  Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers.

Authors:  T Matsuki; K Watanabe; R Tanaka; M Fukuda; H Oyaizu
Journal:  Appl Environ Microbiol       Date:  1999-10       Impact factor: 4.792

Review 7.  Analysis of the intestinal microflora: a renaissance.

Authors:  G W Tannock
Journal:  Antonie Van Leeuwenhoek       Date:  1999 Jul-Nov       Impact factor: 2.271

8.  Culture-independent analysis of fecal microbiota in infants, with special reference to Bifidobacterium species.

Authors:  Shinji Sakata; Toshiki Tonooka; Shinobu Ishizeki; Masaaki Takada; Mitsuo Sakamoto; Masafumi Fukuyama; Yoshimi Benno
Journal:  FEMS Microbiol Lett       Date:  2005-02-15       Impact factor: 2.742

9.  The intestinal microflora of infants: composition of fecal flora in breast-fed and bottle-fed infants.

Authors:  Y Benno; K Sawada; T Mitsuoka
Journal:  Microbiol Immunol       Date:  1984       Impact factor: 1.955

10.  Selective plating underestimates abundance and shows differential recovery of bifidobacterial species from human feces.

Authors:  Juha H A Apajalahti; Anu Kettunen; Päivi H Nurminen; Hanna Jatila; William E Holben
Journal:  Appl Environ Microbiol       Date:  2003-09       Impact factor: 4.792

View more
  6 in total

1.  Changes of fecal Bifidobacterium species in adult patients with hepatitis B virus-induced chronic liver disease.

Authors:  Min Xu; Baohong Wang; Yiqi Fu; Yanfei Chen; Fengling Yang; Haifeng Lu; Yunbo Chen; Jiali Xu; Lanjuan Li
Journal:  Microb Ecol       Date:  2011-08-04       Impact factor: 4.552

2.  Interactions between Bifidobacterium and Bacteroides species in cofermentations are affected by carbon sources, including exopolysaccharides produced by bifidobacteria.

Authors:  David Rios-Covian; Silvia Arboleya; Ana M Hernandez-Barranco; Jorge R Alvarez-Buylla; Patricia Ruas-Madiedo; Miguel Gueimonde; Clara G de los Reyes-Gavilan
Journal:  Appl Environ Microbiol       Date:  2013-09-27       Impact factor: 4.792

3.  Screening of exopolysaccharide-producing Lactobacillus and Bifidobacterium strains isolated from the human intestinal microbiota.

Authors:  Patricia Ruas-Madiedo; José Antonio Moreno; Nuria Salazar; Susana Delgado; Baltasar Mayo; Abelardo Margolles; Clara G de Los Reyes-Gavilán
Journal:  Appl Environ Microbiol       Date:  2007-05-04       Impact factor: 4.792

4.  Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria.

Authors:  Nuria Salazar; Miguel Gueimonde; Ana María Hernández-Barranco; Patricia Ruas-Madiedo; Clara G de los Reyes-Gavilán
Journal:  Appl Environ Microbiol       Date:  2008-06-06       Impact factor: 4.792

5.  Effects of Chronic Bifidobacteria Administration in Adult Male Rats on Plasma Metabolites: A Preliminary Metabolomic Study.

Authors:  Francesca Biggio; Claudia Fattuoni; Maria Cristina Mostallino; Paolo Follesa
Journal:  Metabolites       Date:  2022-08-18

6.  The genome of Bifidobacterium pseudocatenulatum IPLA 36007, a human intestinal strain with isoflavone-activation activity.

Authors:  Ángel Alegría; Susana Delgado; Lucía Guadamuro; Ana Belén Flórez; Giovanna E Felis; Sandra Torriani; Baltasar Mayo
Journal:  Gut Pathog       Date:  2014-07-23       Impact factor: 4.181

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.